Effects and mechanisms of differently cued and non-cued motor imagery in people with multiple sclerosis:A randomised controlled trial by Seebacher, Barbara et al.
Effects and mechanisms of differently cued and non-
cued motor imagery in people with multiple 
sclerosis: A randomised controlled trial 
Barbara Seebacher
1, 2
, Raija Kuisma
1
, Angela Glynn
1
 and 
Thomas Berger
2
1School of Health Sciences 
University of Brighton, UK 
2Clinical Department of Neurology 
Medical University of Innsbruck, Austria 
Corresponding author: 
Seebacher Barbara 
Clinical Department of Neurology 
Medical University of Innsbruck 
Anichstrasse 35 
6020 Innsbruck, Austria 
Mobile: +43.664.3526756 
Phone: +43.512.504.24363 
Fax: +43.5356.73770 
Email: barbara.seebacher@i-med.ac.at 
Keywords: Multiple Sclerosis; Cued Motor Imagery; Walking; Fatigue; Motor 
Imagery Ability; Sensorimotor Synchronisation. 
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
Page 1 from 22
Abstract 
Background: Walking impairment and fatigue are prevalent symptoms in 
people with multiple sclerosis (PwMS). Motor imagery (MI) with rhythmic-
auditory cueing improved walking in PwMS, but so far, the underlying 
mechanisms are not fully explored. 
Objective: This study investigated the effects and mechanisms of differently 
cued and non-cued MI on walking, fatigue and quality of life (QoL) in PwMS. 
Methods: Sixty PwMS with mild to moderate disability were randomised to 
music- and verbally cued MI (MVMI), music-cued MI (MMI) or MI. Participants 
practised cued or non-cued MI of walking for 17 minutes, 6 times per week for 4 
weeks at home. Primary outcomes were walking speed (Timed 25-Foot Walk) 
and walking distance (6-Minute Walk Test). 
Results: Fifty-nine participants completed the study. All interventions induced 
significant improvements in walking speed and distance, while MVMI was 
superior. After cued MI, fatigue and QoL significantly improved, with greatest 
changes seen after MVMI. All participants showed high MI ability. Post-
intervention, sensorimotor synchronisation was significantly more accurate after 
cued MI. 
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Conclusion: All interventions significantly improved walking. MVMI was 
superior in improving walking, fatigue and QoL. Results suggest that MI and 
sensorimotor synchronisation were mechanisms of action. 
Trial registration: ISRCTN Registry, ISRCTN92351899 
(http://www.isrctn.com/) 
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Original Research Paper
Introduction 
Between 75% to 88% of people with multiple sclerosis (PwMS) have walking 
impairment and fatigue, crucially affecting their quality of life (QoL)1. Pyramidal, 
cerebellar, brain stem and sensory symptoms2 are associated with reduced 
walking speed and increased gait variability3. Specific physiotherapy 
approaches such as motor imagery (MI) have been shown to benefit motor 
function and fatigue in people with MS4. MI development was based on the 
notion that motor representations, which are related to the intention and 
preparation of movements, can be consciously accessed via MI5, 6. MI is the 
mental rehearsal of movements without actual execution, involving similar 
spatial and temporal characteristics and brain area activation to executed 
movements5, 7. Internal, first-person perspective refers to a MI experience from 
within the body and external MI to a third-person perspective5. The visual MI 
mode concerns the visualisation of a movement, whereas the kinaesthetic 
mode refers to bodily movement perception7, 8. 
One study was identified that investigated the effects of MI on walking, fatigue 
and quality of life (QoL) in twenty PwMS and found significant improvements in 
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fatigue and QoL but not walking at six-month follow-up4. Another study in 
people with stroke compared the effects of metronome-cued (visual and 
kinaesthetic) MI against non-cued MI on walking and found that metronome-
cued kinaesthetic MI was more effective9. Our previous study results showed 
improvements in walking, fatigue and QoL after rhythmic- cued MI in PwMS 
when compared to controls10. However, underlying mechanisms of action are 
currently unknown. People with cognitive dysfunction11 and depression12 have a 
lower capacity to practise MI and were excluded from the studies. Studies 
suggested to assess MI ability using two different approaches because, while 
some people may have problems generating vivid images and intense 
sensations or describing their imageries, others may struggle with the duration 
of their MI, in relation to executed movements5, 13.  
Cueing of the MI may provide a temporal framework, leading to activation of the 
auditory-motor circuit and rhythmic entrainment, which is the temporal 
synchronisation of neural rhythm processes with regular external cues14. 
Previous findings demonstrate that cues synchronise the motor response so 
that people unconsciously adapt their movement to an external rhythm15. 
Indeed, participants in our study improved their walking, but a further study was 
required to evaluate whether gait synchronisation with the cues (sensorimotor 
synchronisation, SMS) occurred. Therefore, the purpose of this study was to 
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investigate the effects and mechanisms of differently cued and non-cued MI on 
walking, fatigue and QoL in PwMS and assess their MI ability and SMS. 
Methods 
Study design and participants 
This was a prospective three-group single-centre randomised parallel trial 
conducted at the MS-Clinic of the Department of Neurology, Medical University 
of Innsbruck, Austria, from 28 April to 16 August, 2016. Ethical approval was 
received from the Ethic Committees of the Universities of Brighton, UK (no 
approval number, 17 December, 2015) and Innsbruck, Austria (AN2014-0052 
334/4.14-358/5.13(3743a). Information brochures and invitations for study 
participation were displayed in the MS-Clinic and on the Austrian MS Society 
website. Additionally, during their regular visits, PwMS were notified about the 
study by MS-Clinic staff. Upon approval, study participants provided written 
informed consent and were reimbursed for travel expenses only. A CONSORT 
flow diagram is shown in Figure 1 and a CONSORT checklist in Supplementary 
File 2. Research data are available on request (barbara.seebacher@i-
med.ac.at). 
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All eligible and accessible patients were selected for recruitment (consecutive 
sampling). Sixty participants were randomised into one of three groups with a 
1:1:1 allocation ratio using a computer-generated random number sequence 
and sealed, opaque envelopes. Stratified blocked randomisation with allocation 
concealment was performed by an independent researcher, according to 
pertinent predictive factors for a change in walking, specifically age (<40, ≥40), 
gender (female, male) and disability (Expanded Disability Status Scale, EDSS2 
1.5-3.0, 3.5-4.5).  
[Insert-Figure-1] 
Inclusion Criteria were: PwMS with mild to moderate disability (EDSS 1.5-4.5), 
aged ≥18 years, clinically definite MS according to revised McDonald´s 
criteria16, any MS phenotype or ethnicity, German speaking. 
Exclusion Criteria were: Concomitant diseases pot ntially affecting the 
interventions or walking, relapse of MS within the last three months, recent 
change of treatment (physiotherapy, medication) within the last two months 
known to affect walking, pregnancy, clinical symptoms of depression or 
cognitive dysfunction. A relapse or medication change during the intervention 
period necessitated the exclusion of the participant. 
Outcome measures 
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Demographic (gender, age) and MS disease specific data (current EDSS) were 
obtained from patients’ files, study data were collected in the MS-Clinic 
Innsbruck pre and post the 4-week intervention. Current depression (state of 
low mood, loss of activity, sadness, anxiety, awkwardness, loss of appetite, 
insomnia, suicidal thoughts) and/or cognitive dysfunction (impairment in 
orientation, memory, attention, learning, language, visuospatial skills, 
calculating, planning or any other executive function) were clinically evaluated 
by the treating neurologist (TB) before study enrolment. Adverse events were 
recorded during or after a MI s ssion. Withdrawals or other reasons for 
exclusion from the study were recorded.  
Primary outcomes were walking speed and walking distance. Walking speed 
was measured by the Timed 25-Foot Walk (T25FW), a component of the 
Multiple Sclerosis Functional Composite17. Walking distance was assessed by 
the 6-Minute Walk Test (6MWT)18. Consistent with evidence and clinical 
judgement, improvements in walking speed3 and walking distance19 were 
considered clinically significant if they improved by ≥20%.  
Secondary outcomes were fatigue as assessed by the Modified Fatigue Impact 
Scale (MFIS)20, 21 which evaluates the effects of subjective fatigue on physical, 
cognitive and psychosocial functioning. QoL was measured by the MS Impact 
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Scale-29 (MSIS-29)22, 23. Further secondary outcomes were MI ability and SMS. 
MI ability was assessed by the German short version of the Kinaesthetic and 
Visual Imagery Questionnaire (KVIQ-10)24, the KVIQ-G-1025, and the Time-
Dependent Motor Imagery screening test (TDMI)26, a mental chronometry test; it 
requires recording the number of imagined stepping movements over 15, 25, 
and 45 seconds. A cut-off score of 3 out of 5 was used to indicate adequate MI 
ability27. SMS was assessed during gait, with fast and slow music at 110 and 75 
beats per minute (BPM) using a 2-dimensional video-based gait analysis 
system, which was previously described in detail and had been found to be 
reliable and accurate28. Steps were recorded on the central 4.5 metres while 
participants walked 4-6 times on a 30 metre hallway. SMS parameters were 
step time and step length variability and stepwise synchronisation15. 
Assessments were performed at the same time of day, to account for daytime 
fluctuations in fatigue. Blinding was not possible because interventions and 
assessments were performed by one physiotherapist and participants were 
aware of their group allocation. 
Intervention 
The intervention consisted of home-based music- and verbally cued MI (MVMI 
group), music-cued MI (MMI group) and non-cued MI (MI group). A description 
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of the PETTLEP model6 and rhythmic auditory stimulation14 based intervention 
is provided in Figure 2 and Supplementary File 1 and was previously published 
in detail10, 28. The study and intervention duration were based on a review of MI 
interventions8. Four comparable Audio-Mixes were on one CD and changed 
weekly, to maintain attention to the MI14 and facilitate compliance. Participants 
were called once weekly to support their use of MI. 
[Insert-Figure-2] 
Sample size 
The study sample size was based on the pilot study28 between-group 
differences of 20% in walking distance. Using the HyLown Consulting LLC 
Power and Sample Size Calculator (2013), a 5% type I error rate and 80% 
power, the true difference in the three intervention means was expected to be 
20%. Hence, including a 10% attrition rate, 60 participants were required to 
enable the detection of a significant between-group difference.  
Statistical analysis 
SPSS software, release 24.0 (IBM Corporation, Armonk, NY, USA) were used 
for all statistical analyses. Statistical significance was defined as two-tailed p-
value <0.05. Intention-to-treat analysis was performed for all cases with 
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complete follow-up data which were analysed by original assigned groups. 
Descriptive statistics were used to summarise baseline demographic variables. 
Paired T-tests were performed on split file (for group) to detect differences in 
T25FW and 6MWT data between pre- and post-intervention measures. On split 
file, MFIS, MSIS-29, KVIQ-10 and TDMI data, Wilcoxon Signed Ranks tests 
were computed. Bonferroni corrections for multiple comparisons were executed 
as appropriate. Two-Factor Mixed ANOVA was used to test for continuous data, 
with groups as between-subjects factor and time as within-subject factor. 
ANOVA effect size measures were calculated as partial eta squared values (η2). 
For all relevant analyses, significant violations of ANOVA were tested for and 
where appropriate, standard correction procedures were applied. For 
categorical data, Kruskal Wallis test from the differences between post-
intervention and baseline values was calculated, and Dunn´s multiple 
comparisons test conducted. If the overall interaction as significant, Chi-
Square test was used to detect clinically significant changes. 
Adequate MI ability, as assessed by the TDMI screening test, was pre-defined: 
a) there must not be a significant difference between the numbers of imagined 
stepping movements with the left or right lower extremities within the same time 
periods; b) the numbers of imagined movements significantly increase with the 
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duration (Friedman’s ANOVA); and c) the numbers of imagined movements and 
durations are moderately to strongly correlated and the correlations are 
significant. Bivariate Spearman´s correlation coefficients (range) were used.  
Due to non-normal step time data distribution, stepwise synchronisation was 
determined by calculating the ratio of the music beat frequency (BPM) over the 
median cadence15. Assuming normality, the within-subjects gait variability is 
evaluated by the Coefficient of Variation (CV), using the equation 
CV(%)=((SD/Mean)*100). As robust analogues to the SD and CV, the Median 
Absolute Deviation (MAD)29 and the Coefficient of Mean Deviation about the 
Median (CV MAD) were used30. The MAD was calculated analogously to the 
SD, MAD=median(|xi−median(x)|), where the median(X) is the median of the 
sample. Xi are the absolute differences between the sample values and their 
median values; the MAD is the median of these absolute differences30. The CV 
MAD was calculated analogously to the CV.  
Results 
Of 60 randomised participants, 59 completed the study and their data were 
analysed (MVMI group 19, MMI group 20, MI group 20), corresponding with a 
1.7 % attrition rate. One participant was excluded due to a relapse from MS. 
There were no missing data. 
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Baseline characteristics 
As shown in Table 1, 47 females and 12 males completed the study, and their 
mean age was 44.4 (95% CI 41.7, 47.0) years. The median EDSS was 2.5 
(range 1.5, 4.5). There were no significant differences in outcome measures at 
baseline, except lower QoL was observed in the MVMI group. All participants 
were able to perform MI (Supplementary Table 1).  
[Insert-Table-1] 
Safety, adverse events and adherence 
No adverse events were reported. Participants reported that the home-based 
intervention was safe and convenient and they appreciated the phone call 
support. They recorded their practice sessions in a diary and reported median 
practice of 5 (4-6) times per week.  
Primary outcomes 
Within-group comparisons showed that all three interventions significantly 
improved walking speed and walking distance (Figure 3). 
[Insert-Figure-3] 
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Between-group analyses demonstrated an overall significant group difference 
from baseline to post-intervention: T25FW: F(2,56)=4.65, p=0.013, with a 
medium effect size of η2=0.143. MVMI was superior to MI in effectiveness 
(p=0.024). There was an overall significant group difference in walking distance 
from baseline to post-intervention: F(2,56)=3.53, p=0.036, η2=0.112. The effect 
of MVMI (p=0.001) versus MI was significant. Walking improvements were 
similar in participants irrespective of disability level (Supplementary Figure 3). 
Intervention effects on walking are shown in Table 2. 
[Insert-Table-2] 
Secondary outcomes 
Intervention effects on subjective fatigue and QoL for all groups are shown in 
Table 3 and Supplementary Figures 1-2.  
Within-group analyses showed that physical, cognitive and total fatigue and 
physical QoL significantly improved only after cued MI (MVMI, MMI) and 
psychosocial fatigue significantly improved in all groups (all p-values <0.01). 
Psychological QoL improved only after MVMI (p=0.030).  
Between-group comparisons in psychosocial fatigue showed a significant 
superiority of MVMI over MI (p=0.041). Post-intervention, an overall 
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improvement in physical QoL was observed (p=0.007). Post-hoc analyses 
showed that only the MVMI group contributed to this improvement (p=0.005). 
Thirty-two out of 59 participants reached a clinically significant improvement in 
physical QoL of whom significantly more participants were in the MVMI group 
(p=0.030).  
[Insert-Table-3] 
Intervention effects on MI ability are shown in Figure 4 and Supplementary 
Table 1. Post-intervention, overall, participants improved their MI ability, as 
evidenced by median KVIQ-G-10 values of 4.1 (range 2.9-5.0) out of 5.0. In all 
groups, the medians were higher than the cut-off value of 3 points for adequate 
visual and kinaesthetic MI ability. There was no group X time interaction in MI 
capability. 
Post-intervention, improvement in MI abilities was also shown by the TDMI 
screening test. The numbers of imagined stepping movements and durations 
were strongly correlated and significant, as indicated by a median Spearman’s ρ 
of 0.91 (range 0.88, 0.95).  
[Insert-Figure-4] 
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Intervention effects on SMS are presented in Figure 5 and Supplementary 
Table 2. With fast music, significant improvements in step length variability were 
only seen after music-cued MI (p=0.045) while group X time interactions were 
significant (MVMI p=0.031; MMI p=0.015). Step time variability even worsened 
in the MI group (p=0.030). 
With slow music, following MVMI (p=0.003) and MMI (p<0.001) but not MI, step 
length variability improved while interactions were still significant (MVMI 
p=0.030; MMI p=0.006). Step time variability improved solely after MMI 
(p=0.018) and the group comparison was still significant (p=0.008). Stepwise 
synchronisation worsened after MI (p=0.036). Group interaction analyses 
showed significant differences in stepwise synchronisation, in favour of MVMI 
(p=0.001) and MMI (p=0.008) compared with MI.  
[Insert-Figure-5] 
Discussion 
Results showed that cued and non-cued MI improved walking speed and 
walking distance in PwMS, represented by medium effect sizes, but MVMI was 
more effective than MI in improving walking, subjective fatigue and QoL. 
Overall, these results agree with our previous study10 and a gait training study in 
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PwMS, where walking significantly improved after metronome-cued versus non-
cued gait training31. Consistent with our findings, people with stroke improved 
their walking mainly after cued kinaesthetic MI when compared to visual or non-
cued kinaesthetic MI9. 
The effects of non-cued MI on walking were greater than those seen by a small 
non-controlled study, demonstrating significant improvements in fatigue and 
QoL, but not in walking speed, after five weeks of MI in PwMS4. We observed 
improvement in fatigue and QoL only after cued MI, with MVMI being superior. 
The discrepancy in results could be related to the difference in intervention, 
which included various executed movements alongside MI whereas our study 
used MI of walking only. In absence of a control group we acknowledge that 
natural fluctuations in fatigue and walking speed could also have been a factor.  
In our study, music-cued MI but not MI alone improved fatigue and QoL while 
MVMI was most effective, suggesting these findings are related to the effects of 
music and verbal cueing. Studies have evidenced effects of music on mood, 
motivation, arousal, perceived effort32 and cognitive performance14, and so 
music could impact on MI. Verbal cueing could have intensified the cueing and 
directed the attention towards relevant movement aspects.  
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MI capability was measured to test whether it could, at least partially, explain 
any changes seen. At baseline, all participants were found to be able to perform 
MI. KVIQ-10 scores were consistent with those from another study in thirty 
PwMS11. TDMI screening test results were suggestive of high MI capability26. It 
is likely that the MI familiarisation facilitated participants’ understanding of MI 
and enhanced their performance during the assessments and practice6, 8. MI 
was, thus, considered a potential mechanism of action. 
SMS was explored during gait with fast and slow music. Overall, cued MI was 
found to be significantly more effective for SMS than MI alone. In all likelihood, 
the rhythmic-cued walking imagery practice positively impacted on the 
spatiotemporal gait variability, comparable to rhythmic auditory simulation 
(RAS) during real walking. In agreement with this, a study in twelve people with 
Parkinson’s disease and healthy controls showed significantly improved 
variability of step time and step length, but only in patients who followed cueing 
while walking cued gait training did not change the gait variability in healthy 
controls33. Another recent study has compared the effects of four weeks of cued 
versus un-cued gait training on gait parameters in people with stroke. 
Significantly improved gait was observed only when RAS was used34.  
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There are several limitations to this study. Data were collected before and after 
the four-week intervention period, but there is no follow-up data. No phone calls 
were made after the intervention period. Therefore, no statement can be made 
regarding long-term effects of the MI. Screening for cognitive impairment and 
depression was performed clinically, but no validated assessments were used. 
Therefore, some impairment could have been overlooked in some participants. 
There were significant between-group differences in baseline QoL, with poorer 
QoL in the MVMI group, who might have had a greater potential for 
improvement. Although pretested in our pilot study, the stride-to-stride variability 
measurement could have been confounded by the variability between trials and 
the inability to capture at least 10 consecutive steps for every participant. 
Further, biomechanical differences between walking with and without shoes 
during the testing could have influenced the results35. Blinding was not possible 
as one physiotherapist was responsible for instructions and assessments 
however a script was used for consistency. Participants realised their group 
allocation although there was a true uncertainty regarding the results.  
Conclusions 
Study results demonstrated that four weeks of cued and non-cued MI with 
weekly phone calls significantly improved walking in PwMS with mild to 
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moderate disability. MVMI was most effective in improving walking, fatigue and 
QoL. After familiarisation with MI, participants were able to perform MI. SMS 
was significantly more accurate after cued MI when compared to MI alone. 
Therefore, the improvements in walking may be attributed to the MI and SMS. 
This contributes to the growing evidence base supporting the use of MI and 
SMS to improve gait in PwMS.  
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Table 1: Participant baseline characteristics. 
Parameter MVMI group 
N=19 
MMI group 
N=20 
MI group 
N=20 
p-value 
Gender
 a
 (F/M) N=15:4 N=16:4 N=16:4 0.996
 
Age (years)
 b 
45.3 (39.8, 50.8) 44.5 (40.5, 48.5) 43.3 (38.3, 48.3) 0.826 
EDSS total
 c
 3.0 (1.5, 4.5) 2.5 (1.5, 4.5) 2.5 (1.5, 4.5) 0.925
 
Abbreviations: MVMI: music and verbally cued motor imagery; MMI: music-cued MI; N: number 
of participants; F/M: Females/Males; EDSS: Expanded Disability Status Scale. 
a
Number of participants, analysed with Chi-Square test. 
b
Mean (95% CI), analysed with One-Way ANOVA. 
c
Median (range), analysed with Kruskal-Wallis test. 
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Table 2: Effect of interventions on primary outcomes and clinically significant improvement. 
Parameter MVMI group 
N=19 
MMI group 
N=20 
MI group 
N=20 
Overall 
p-value 
T25FW (seconds) 
Baseline
.a 
6.1 (5.2, 7.0) 6.1 (4.9, 7.3)
 
5.6 (4.7, 6.4)
 
0.602
 
Post-intervention
.a 
Change from baseline
 a 
5.3 (4.5, 6.1) 
-0.8 (-1.0, -
0.6)* 
5.2 (4.4, 6.0) 
-0.9 (-1.4, -0.4) 
5.3 (4.4, 6.1) 
-0.3 (-0.5, 
0.06) 
 
0.013 
Clin. sig. improvement (≥20%)
 b 
N=3 (21.1%) N=3 (15.0%) N=0 (0.0%) 0.110 
6MWT (metres) 
Walking aid use during 6MWT
 a
 
No/uni-/bilateral aid N=16/2/1 N=19/0/1 N=18/0/2  
Baseline
.a
 457.3 (394.3, 
520.3) 
461.7 (395.5, 
528.0) 
461.7 (395.5, 
528.0) 
0.937 
Post-intervention
 a 
 
Change from baseline
 a 
510.3 (450.5, 
570.2) 
53.0 (38.2, 
67.7)** 
499.1 (433.8, 
564.3) 
37.3 (12.4, 
62.3) 
491.7 (424.0, 
559.5) 
19.1 (4.8, 
33.5) 
 
 
0.036 
Clin. sig. improvement (≥20%)
 b 
N=5 (26.3%)
 
N=2 (10.0%) N=1 (5.0%) 0.128 
Abbreviations: MVMI: music- and verbally cued motor imagery; MMI: music-cued MI; T25FW: 
Timed 25-Foot Walk; 6MWT: 6-Minute Walk Test; Clin. sig. improvement: clinically significant 
improvement; N: number of participants. 
With walking speed (T25FW), improvement is indicated by a minus and worsening by a plus; 
with walking distance (6MWT), improvement is indicated by a plus and worsening by a minus. 
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a
Mean (95% CI); significance of group differences analysed with Mixed Design ANOVA; if 
overall p-value significant, post hoc pairwise comparisons between groups with Bonferroni 
correction for 3 comparisons: *p<0.05, **p≤0.001 
b
Analysed with Chi-Square test. 
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Table 3: Effect of interventions on fatigue and quality of life and clinically significant 
improvement. 
Parameter MVMI group 
N=19 
MMI group 
N=20 
MI group 
N=20 
Overall p-
value 
MFIS total score 
Baseline
.a
 43.0 (11.0, 
72.0) 
28.5 (2.0, 69.0) 33.0 (2.0, 54.0) 0.209
 
Post-intervention
 a
 27.0 (1.0, 55.0) 19.5 (0.0, 45.0) 23.5 (2.0, 52.0)  
Change from baseline
 a 
-12.0 (-31.0, 
5.0) 
-10.0 (-37.0, 
7.0) 
-4.0 (-40.0, 
11.0) 
0.197 
Clin. sig. improvement
 b
 N=6 (31.6%) N=7 (35%) N=6 (30%) 0.942 
MSIS-29 physical subscore 
Baseline
.a
 47.5 (12.5, 
76.2) 
25 (6.2, 56.2) 21.9 (3.7, 63.7) 0.010
 
Post-intervention
 a
 25.0 (5.0, 61.2) 21.2 (2.5, 37.5) 16.2 (2.5, 51.2)  
Change from baseline
 a 
-15.0 (-38.7,  
-1.2)* 
-7.5 (-28.7, 8.7) -3.1 (-41.2, 8.7) 0.007 
Clin. sig. improvement
 c 
N=15 (78.9%)* N=10 (50%) N=7 (35%) 0.020 
MSIS-29 psychological subscore 
Baseline
.a
 33.3 (2.8, 66.7) 19.4 (0.0, 47.2) 13.9 (0.0, 66.7) 0.005
 
Post-intervention
 a
 25.0 (2.8, 50.0) 11.1 (0.0, 36.1) 8.3 (0.0, 52.8)  
Change from baseline
 a 
 
-11.1 (-50.0, 
16.7) 
-2.3 (-19.4, 
13.9) 
-1.4 (-38.9, 
19.4) 
0.233 
Clin. sig. improvement
 c 
N=12 (63.2%) N=9 (45%) N=8 (40%) 0.317 
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Abbreviations: MVMI: music and verbally cued motor imagery; MMI: music-cued MI; Clin. sig. 
improvement: Clinically significant improvement; MFIS: Modified Fatigue Impact Scale; MSIS-
29: Multiple Sclerosis Impact Scale-29. 
a
Median (range); significance of group differences analysed with Kruskal Wallis test; if overall p-
value significant, post hoc pairwise comparisons between groups with Dunn´s multiple 
comparisons test: *p<0.05. 
b
Improvement in fatigue was regarded clinically significant when there was a reduction of 16.2 
points on the total MFIS score, 8.9 points on the physical subscale, 8 points on the cognitive 
subscale, and 2.3 points on the psychosocial subscale (Rietberg, Van Wegen and Kwakkel 
2010, reference number 21). 
c
Changes in QoL were considered clinically significant if the reduction on the MSIS-29 physical 
subscale was 7.5 points and on the psychological subscale 5.56 points (Van der Linden et al. 
2005, reference number 22). 
b, c
Analysed with Chi-Square test; if overall p-value significant, analysed with Fisher´s Exact test 
and corrected for multiple comparisons: *p<0.05. 
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Figure 1: CONSORT Flow Chart. 
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Figure 2: Intervention. 
Abbreviations: MI: Motor Imagery. 
Familiarisation with MI was used according to a review (Schuster et al. 2011, 
reference number 8). The PETTLEP approach to MI was developed by Holmes and 
Collins 2001, reference number 6) 
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Figure 3: Effect of intervention on walking speed and walking distance. 
Figure legend: Abbreviations: MVMI: music- and verbally cued MI; MMI: music-cued 
MI; MI: motor imagery; T25FW: Timed 25-Foot Walk Test; 6MWT: 6-Minute Walk 
Test. (A) Walking speed and (B) walking distance; small square brackets above the 
figure indicate significant within-group comparisons between baseline and post-
intervention; h-beams indicate significant group X time interactions. Grey circles and 
black squares show means, and error bars indicate 95% confidence intervals; *p-
value <0.05; **p-value <0.01; ***p-value <0.001. 
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Figure 4: Effect of intervention on total motor imagery ability and motor imagery 
ability, as assessed by mental chronometry. 
Figure legend: Abbreviations: MVMI: music- and verbally cued MI; MMI: music-cued 
MI; MI: motor imagery; KVIQ-10: Kinaesthetic and Visual Imagery Questionnaire-10; 
TDMI: Time-Dependent Motor Imagery screening test. Motor imagery ability: (A) 
vividness of images and intensity of sensations (KVIQ-10); (B) mental chronometry; 
correlations between the number of imagined stepping movements within three time 
periods of 15, 25 and 45 seconds, with the right and left lower extremities (all 
correlations are significant at the 0.01 level). Medians are shown by lines in the 
centre of the box-plots; the 25th-75th percentiles are indicated by the boxes and the 
range by the whiskers. Dashed lines represent the cut-off value for acceptable to high 
MI ability: (A) 30 points on the KVIQ-10; (B) very strong significant correlation, rho 
between 0.8 and 1.0. Square brackets on top of the figures show significant within-
group comparisons between baseline and post-intervention; *p-value <0.05. 
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Figure 5: Effect of intervention on sensorimotor synchronisation. 
Figure legend: Abbreviations: MVMI: music- and verbally cued MI; MMI: music-cued 
MI; MI: motor imagery. (A) Step length variability, (B) step time variability and (C) 
stepwise synchronisation with music at 110 beats per minute (BPM); (D; E; F) 
corresponding parameters with music at 75 BPM. Grey circles and black squares 
show medians and interquartile ranges. Small square brackets on top of the figures 
show significant within-group comparisons between baseline and post-intervention; 
h-beams indicate significant group X time interactions. (C, G) Dashed lines show the 
optimum synchronisation ratio at 1.0; *p-value <0.05; **p-value <0.01; ***p-value 
<0.001. 
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CONSORT 2010 Flow Diagram 
Assessed for eligibility (n=611) 
Meeting inclusion criteria (n=252) 
 
Allocated to intervention 1 (n=20) 
received usual treatment (n=20) 
received allocated intervention 
and weekly phone calls (n=20) 
did not receive allocated 
intervention (n=0) 
Allocation 
Analysis 
Follow-up 
Randomised 
(n=60) 
Enrolment 
Allocated to intervention 2 (n=20) 
received usual treatment (n=20) 
received allocated intervention 
and weekly phone calls (n=20) 
did not receive allocated 
intervention (n=0) 
Lost to follow-up (n=1) 
Discontinued intervention 
(n=0) 
Lost to follow-up (n=0) 
Discontinued intervention 
(n=0) 
Lost to follow-up (n=0) 
Discontinued intervention 
(n=0) 
Analysed (n=19) 
 
Excluded from analysis (n=1) 
Analysed (n=20) 
 
Excluded from analysis (n=0) 
Analysed (n=20) 
 
Excluded from analysis (n=0) 
Not meeting 
inclusion criteria 
(n=359)  
refused to participate 
(n=116) 
other reasons (lack of time, 
transport) (n=49) 
indicated their wish to 
participate later (n= 12) 
 
 
 
Allocated to intervention 3 
(n=20) 
received usual treatment 
(n=20) 
received allocated intervention 
and weekly phone calls (n=20) 
Did not receive allocated 
intervention (n=0) 
Pilot study 
(n=15) 
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Supplementary File 1: Intervention. 
The intervention consisted of home-based music- and verbally cued MI (MVMI 
group), music-cued MI (MMI group) and non-cued MI (MI group). After the 
randomisation and prior to the intervention, study participants were individually 
familiarised with (cued) MI, as suggested in previous studies1. The PETTLEP 
approach was used as an interventional MI model, involving the “Physical, 
Environmental, Task, Timing, Learning, Emotional, and Perspective” components of 
MI2. The PETTLEP elements relate to the physical, or bodily, position of the 
practitioner including arousal, the imagined environment, the imagined task, the MI 
timing, the learning or changes induced by the MI, the emotions or affective states, 
which refer to the MI task, and the MI perspective. These elements were applied to 
the current study.  
The participants were informed in lay language about the concept of MI and its 
application in sports and neurorehabilitation. The new approach of rhythmic-cued MI 
was introduced. Examples of Rhythmic Auditory Stimulation3 were described, that is, 
music cues with gait training, plus their use in neurorehabilitation. In addition, 
participants were educated about the two perspectives (internal, first-person and 
external, third-person) and the modes of MI (kinaesthetic and visual). After that, 
under the supervision of the researcher, participants practised MI and became aware 
of their preferred mode or perspective. The researcher highlighted internal, 
kinaesthetic MI, which was adopted for this study. Participants were asked for MI 
content features such as the mode and perspective they were using, for the 
environment or for movement aspects they were imagining. Moreover, to receive 
information about the temporal coupling of the actual and imagined movements, the 
duration of actual and imagined walking along a marked 6-metre pathway was 
compared4. The time was measured and reported back to the participants who were 
allowed to repeat the imagery tasks several times. 
Based on the PETTLEP approach, the MI script included different elements: 
1. Position (Physical): Participants were asked to practise at any time of the day 
when they were alert. They were frequently reminded to keep their eyes closed and 
breath normally, sit in an upright body position and relax their shoulders. They were 
informed that they should avoid tightening their muscles or moving. 
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2. Environment: Participants were asked to practice in a quiet place at home. They 
were instructed to imagine themselves walking indoors (long hallway similarly to that 
in the MS Clinic) and walking outdoors (on a straight path participants are familiar 
with).  
3. Tasks: The imagery scripts slightly changed weekly and remained the same 
throughout the week. The instructions were: “take long/giant strides; roll your feet on 
the ground and feel your body weight on your soles; touch the ground with your heels 
first; raise the front of your feet/your knees; pace; place/feel your weight on your 
feet/legs; stamp your feet while walking; walk effortlessly, almost as if you were 
floating; walk forcefully and energetically as if you were an athlete; march as if you 
were in the army; walk in an extremely upright posture such as when balancing a 
sachet, filled with rice, on your head; feel the swinging of your arms/legs while 
walking.” 
4. Timing: In the MVMI group, ext rnal timing was provided: “imagine yourself 
walking in time with the music and v rbal cues”. In the MMI group, external timing 
was provided: “imagine yourself walking in time with the music”. In both cued MI 
groups, the cueing tempo was between 80 and 120 BPM and slow, medium and fast 
music pieces alternated, with a general progression in the tempo. The cueing tempo 
was consistent with an imagined walking tempo at 80 to 120 steps per minute. In the 
MI group, timing was internal and depended on the tempo and intensity of the 
walking tasks 
5. Learning: See familiarisation; additionally, weekly phone call support was 
individually provided for participants in all groups. 
6. Emotion: In the music-verbal-MI group, motivational instrumental music was used 
with the MI whilst in the metronome-verbal-MI group, simple metronome cues were 
employed. In all groups, the MI instructions and cues included motivational and 
arousal enhancing aspects (e.g. walk forcefully and energetically as if you were an 
athlete; stamp-stamp). See instructions under Tasks. 
7. Perspective: Participants were asked to use kinaesthetic MI from an internal, first-
person perspective. 
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In the MVMI and MMI groups, cueing of the MI was provided by instrumental 
(karaoke) music. A selection of the music type and beat was based on a published 
summary of practical guidelines and recent publications3: rhythmic cueing was in a 
2/4 or 4/4 metre with strong ON and OFF beat patterns, which means that every first 
or every first and third beats were stressed.  
Additional verbal cueing was used in the MVMI group. The literature shows that three 
to four different verbal cues are useful in early learning stages and seven to nine 
cues improve more advanced motor learning stages. By contrast, a higher number of 
cues might confuse participants and detract them from the motor task5. In the current 
study, the verbal cueing was applied accordingly. For part one of the CDs, four verbal 
cues were used (“step-step”, “stamp-stamp”, “large-step” and “toe-off”). These cues 
were reused in parts two to four with gradually added new cues (“upright”, “strike-
heel”, “roll-foot”, “pace-pace” and “swing-swing”)5. The verbal emphasis was placed 
on the beats accordingly such that with a 4/4 metre, every first and third beat were 
stressed, and with a 2/4 metre, every first beat was emphasised. At the same time, 
every first beat was dedicated to one leg, such as the right leg, and every second 
beat was for the other leg. 
In the MI group, no cueing was employed. 
The MI instructions with or without music or verbal cues were on a CD prepared for 
this study by the researcher (using GarageBand, Apple Inc.), as the intervention was 
home-based. If no CD player was available, participants could access the audio mix 
via a Dropbox link and download it on their smartphones, laptop, tablet or MP3-
player. The audio mix should be clearly audible for participants, who were allowed to 
use headphones or earphones, if desired. 
After the familiarisation and verbal instructions, participants received the CD 
consistent with their group allocation. They were asked to practice kinaesthetic MI of 
walking 6 times a week and once a day for 17 minutes over 4 weeks. Weekly phone 
calls were provided also as a reminder on the practice. After each week, the audio 
mix was changed to enhance attention towards the MI3 and to facilitate adherence, 
so that four mixes, designed in the same way, were on one CD. The duration of both 
the practice and the study were based on the current literature on MI, showing an 
average study duration of thirty-four days; however, with a practice intensity of three 
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times a week, for seventeen minutes1, 6. The actual practice frequency was noted in a 
diary but could not be directly assessed. Weekly participant reports on their practice 
frequency were recorded. 
References: 
1. Schuster C, Hilfiker R, Amft O, et al. Best practice for motor imagery: a systematic literature 
review on motor imagery training elements in five different disciplines. BMC Med. 2011; 9: 75. 
2. Holmes PS and Collins DJ. The PETTLEP approach to motor imagery: A functional equivalence 
model for sport psychologists. J Appl Sport Psychol. 2001; 13: 60-83. 
3. Thaut MH. Rhythm, music and the brain. Scientific foundations and clinical applications. 
Oxon: Routledge, 2005. 
4. Malouin F, Richards CL, Durand A and Doyon J. Reliability of mental chronometry for 
assessing motor imagery ability after stroke. Arch Phys Med Rehabil. 2008; 89: 311-9. 
5. Edwards WH. Motor learning and control: from theory to practice. Belmont: Wadsworth, 
2011. 
6. Catalan M, De Michiel A, Bratina A, et al. Treatment of fatigue in multiple sclerosis patients: a 
neurocognitive approach. Rehabilitation research and practice. 2011: 670537. 
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CONSORT 2010 checklist  Page 1 
CONSORT 2010 checklist of information to include when reporting a randomised trial* 
 
Section/Topic 
Item 
No Checklist item 
Reported 
on page No 
Title and abstract 
 1a Identification as a randomised trial in the title Title page 
1b Structured summary of trial design, methods, results, and conclusions (for specific guidance see CONSORT for abstracts) 2 
Introduction 
Background and 
objectives 
2a Scientific background and explanation of rationale 3-5 
2b Specific objectives or hypotheses 4-5 
Methods 
Trial design 3a Description of trial design (such as parallel, factorial) including allocation ratio 5 
3b Important changes to methods after trial commencement (such as eligibility criteria), with reasons NA 
Participants 4a Eligibility criteria for participants 6 
4b Settings and locations where the data were collected 5; 7 
Interventions 5 The interventions for each group with sufficient details to allow replication, including how and when they were 
actually administered 
8-9; Figure 2; 
Supplementar
y File 1 
Outcomes 6a Completely defined pre-specified primary and secondary outcome measures, including how and when they 
were assessed 
6-8 
6b Any changes to trial outcomes after the trial commenced, with reasons NA 
Sample size 7a How sample size was determined 9 
7b When applicable, explanation of any interim analyses and stopping guidelines NA 
Randomisation:    
 Sequence 
generation 
8a Method used to generate the random allocation sequence 6 
8b Type of randomisation; details of any restriction (such as blocking and block size) 6 
 Allocation 
concealment 
mechanism 
9 Mechanism used to implement the random allocation sequence (such as sequentially numbered containers), 
describing any steps taken to conceal the sequence until interventions were assigned 
6 
 Implementation 10 Who generated the random allocation sequence, who enrolled participants, and who assigned participants to 
interventions 
6 
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CONSORT 2010 checklist  Page 2 
Blinding 11a If done, who was blinded after assignment to interventions (for example, participants, care providers, those 
assessing outcomes) and how 
8 
11b If relevant, description of the similarity of interventions 8-9; 
Supplementar
y File 1 
Statistical methods 12a Statistical methods used to compare groups for primary and secondary outcomes 9-11 
12b Methods for additional analyses, such as subgroup analyses and adjusted analyses NA 
Results 
Participant flow (a 
diagram is strongly 
recommended) 
13a For each group, the numbers of participants who were randomly assigned, received intended treatment, and 
were analysed for the primary outcome 
Figure 1 
13b For each group, losses and exclusions after randomisation, together with reasons Figure 1; 11 
Recruitment 14a Dates defining the periods of recruitment and follow-up 5 
14b Why the trial ended or was stopped 11 
Baseline data 15 A table showing baseline demographic and clinical characteristics for each group Table 1 
Numbers analysed 16 For each group, number of participants (denominator) included in each analysis and whether the analysis was 
by original assigned groups 
Figure 1; 9-10 
Outcomes and 
estimation 
17a For each primary and secondary outcome, results for each group, and the estimated effect size and its 
precision (such as 95% confidence interval) 
Tables 2-4 
Figures 3-5 
Supplementar
y Tables 1-2 
Supplementar
y Figures 1-3 
Pages 12-15 
17b For binary outcomes, presentation of both absolute and relative effect sizes is recommended NA 
Ancillary analyses 18 Results of any other analyses performed, including subgroup analyses and adjusted analyses, distinguishing 
pre-specified from exploratory 
NA 
Harms 19 All important harms or unintended effects in each group (for specific guidance see CONSORT for harms) 12 
Discussion 
Limitations 20 Trial limitations, addressing sources of potential bias, imprecision, and, if relevant, multiplicity of analyses 18 
Generalisability 21 Generalisability (external validity, applicability) of the trial findings 18-19 
Interpretation 22 Interpretation consistent with results, balancing benefits and harms, and considering other relevant evidence 15-19 
Other information  
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CONSORT 2010 checklist  Page 3 
Registration 23 Registration number and name of trial registry 2 
Protocol 24 Where the full trial protocol can be accessed, if available Corresponding 
author 
Funding 25 Sources of funding and other support (such as supply of drugs), role of funders 19 
*We strongly recommend reading this statement in conjunction with the CONSORT 2010 Explanation and Elaboration for important clarifications on all the items. If relevant, we also 
recommend reading CONSORT extensions for cluster randomised trials, non-inferiority and equivalence trials, non-pharmacological treatments, herbal interventions, and pragmatic trials. 
Additional extensions are forthcoming: for those and for up to date references relevant to this checklist, see www.consort-statement.org. 
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Supplementary Table 1: Effect of interventions on visual, kinaesthetic and total motor imagery 
ability and motor imagery ability, as assessed by mental chronometry. 
Parameter MVMI group 
N=19 
MMI group 
N=20 
MI group 
N=20 
Overall 
p-value 
KVIQ-G-10 visual subscale 
Baseline
.a
 18.0 (14.0, 
25.0) 
18.0 (13.0, 
25.0) 
20.0 (14.0, 
25.0) 
0.386 
Median visual subscale
 a
 3.6 (2.8, 5.0) 3.6 (2.6, 5.0) 4.0 (2.8, 5.0)  
Post-intervention
 a
 19.0 (15.0, 
25.0) 
20.0 (14.0, 
25.0) 
22.0 (13.0, 
25.0) 
 
Median visual subscale
 a 
3.8 (3.0, 5.0) 4.0 (2.8, 5.0) 4.4 (2.6, 5.0)  
Change from baseline
 a 
1.0 (-2.0, 9.0) 1.5 (-4.0, 8.0) 1.5 (-4.0, 10.0) 0.923 
KVIQ-G-10 kinaesthetic subscale 
Baseline
.a
 19.0 (13.0, 
25.0) 
20.0 (12.0, 
25.0) 
18.0 (13.0, 
25.0) 
0.438 
Median visual subscale
 a
 3.8 (2.6, 5.0) 4.0 (2.4, 5.0) 3.6 (2.6, 5.0)  
Post-intervention
 a
 21.0 (13.0, 
25.0) 
21.0 (14.0, 
25.0) 
21.0 (16.0, 
25.0) 
 
Median kinaest subscale
 a
 4.2 (2.6, 5.0) 4.2 (2.8, 5.0) 4.2 (3.2, 5.0)  
Change from baseline
 a 
1.0 (-2.0, 6.0) 2.0 (-4.0, 7.0)* 2.0 (-3.0, 6.0)* 0.336 
KVIQ-G-10 total score 
Baseline
.a
 37.0 (31.0, 
49.0) 
38.0 (29.0, 
50.0) 
35.0 (29.0, 
50.0) 
0.925 
Median visual subscale
 a
 3.7 (3.1, 4.9) 3.8 (2.9, 5.0) 3.5 (2.9, 5.0)  
Post-intervention
 a
 40.0 (32.0, 
50.0) 
41.0 (35.0, 
50.0) 
42.0 (29.0, 
50.0) 
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Median total score
 a
 4.0 (3.2, 5.0) 4.1 (3.5, 5.0) 4.2 (2.0, 5.0)  
Change from baseline
 a 
1.0 (-2.0, 12)* 2.5 (-5.0, 13.0)* 3.0 (-6.0, 16.0) 0.745 
Time-Dependent Motor Imagery screening test (TDMI) at baseline 
25 seconds right 
a
 14.0 (9.0, 25.0) 15.0 (9.0, 23.0) 14.0 (9.0, 22.0)  
15 seconds left 
a 
9.0 (6.0, 18.0) 10.0 (6.0, 16.0) 8.0 (5.0, 14.0)  
45 seconds right 
a
 27.0 (18.0, 
41.0) 
28.0 (18.0, 
41.0) 
25.0 (15.0, 
39.0) 
 
15 seconds left 
a 
10.0 (6.0, 17.0) 10.0 (7.0, 15.0) 9.0 (5.0, 14.0)  
25 seconds left 
a
 16.0 (9.0, 26.0) 16.0 (9.0, 23.0) 14.0 (8.0, 21.0)  
Spearman’s ρ
a, b 0.94 (0.87, 
0.98) 
0.86 (0.76, 
0.92) 
0.90 (0.85, 
0.87) 
 
TDMI at post-intervention 
25 seconds right 
a
 16.0 (12.0, 
30.0) 
19.0 (12.0, 
26.0) 
19.0 (11.0, 
25.0) 
 
15 seconds left 
a 
11.0 (8.0, 19.0) 12.0 (8.0, 18.0) 12.0 (7.0, 16.0) 
 
45 seconds right 
a
 27.0 (18.0, 
41.0) 
28.0 (18.0, 
41.0) 
25.0 (15.0, 
39.0) 
 
15 seconds left 
a 
10.0 (6.0, 17.0) 10.0 (7.0, 15.0) 9.0 (5.0, 14.0) 
 
25 seconds left 
a
 17.0 (12.0, 
29.0) 
18.0 (13.0, 
26.0) 
18 (11.0, 25.0)  
Spearman’s ρ
a, b 0.95 (0.91, 
0.98) 
0.90 (0.85, 
0.96) 
0.91 (0.78, 
0.96) 
 
Abbreviations: KVIQ-G-10: Kinaesthetic and Visual Imagery Questionnaire-10, German short 
version; N: number of participants; kinaest: kinaesthetic; sub: subscale;  
a
Median (range); significance of group differences analysed with Kruskal Wallis test; if overall p-
value significant, post hoc pairwise comparisons between groups with Dunn´s multiple 
comparisons test: *p<0.05. Median motor imagery vividness scores were calculated by dividing 
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the median KVIQ-G-10 scores by the number of items, that is, 5 for the visual and kinaesthetic 
subscales, and 10 for the total score. 
b
10 pairwise correlations; all correlations were significant at ≤0.01 (two-tailed). 
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Supplementary Table 2: Effect of interventions on gait variability and stepwise synchronisation. 
Parameter MVMI group 
N=19 
MMI group 
N=20 
MI group 
N=20 
Overall 
p-value 
Fast music trial, 110 BPM
 
Step length variability
 
Baseline
.a
 2.22 (0.85, 6.33) 3.03 (1.20, 5.66) 2.14 (1.28, 6.52) 0.610 
Post-intervention
 a
 1.72 (0.78, 3.74) 1.93 (0.00, 4.17) 1.94 (1.54, 4.95)  
Change from baseline
 a
 -0.80 (-2.13, 1.50) -0.75 (-2.71, 1.46) -0.06 (-3.16, 
1.67) 
0.462 
Step time variability 
Baseline
.a
 1.92 (0.00, 6.60) 3.45 (0.00, 8.77) 1.83 (0.00, 8.77) 0.169 
Post-intervention
 a
 1.85 (0.00, 6.67) 1.96 (0.00, 6.76) 2.67 (0.00, 
10.34) 
 
Change from baseline
 a
 -1.38 (-3.57, 
1.88)* 
-1.82 (-6.90, 
3.85)* 
1.71 (-3.33, 
3.85) 
0.008 
Stepwise synchronisation 
Baseline
.a
 1.03 (0.90, 1.94) 1.02 (0.81, 1.28) 1.04 (0.93, 1.37) 0.358 
Post-intervention
 a
 0.99 (0.97, 1.37) 0.99 (0.92, 1.36) 1.04 (0.95, 1.37)  
Change from baseline
 a
 -0.04 (-0.57, 0.07) -0.02 (-0.11, 0.15) 0.00 (-0.06, 
0.04) 
0.131 
Slow music trial, 75 BPM 
Step length variability 
Baseline
.a
 2.61 (0.96, 5.22) 2.80 (1.59, 7.77) 2.04 (1.27, 7.87) 0.308 
Post-intervention
 a
 1.72 (0.78, 3.74) 1.93 (0.00, 4.17) 1.94 (1.54, 4.95)  
Change from baseline
 a
 -0.89 (-2.36, 
0.86)* 
-0.76 (-5.79, 
0.25)** 
0.03 (-3.32, 
1.58) 
0.004 
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Step time variability 
Baseline
.a
 2.70 (0.00, 5.00) 3.39 (1.37, 9.33) 2.50 (0.00, 
17.24) 
0.490 
Post-intervention
 a
 2.50 (0.00, 4.29) 2.50 (0.00, 8.11) 2.76 (0.00, 
18.97) 
 
Change from baseline
 a
 -0.13 (-3.33, 3.80) -1.31 (-3.66, 
3.50)** 
0.07 (-4.62, 
3.23) 
0.011 
Stepwise synchronisation 
Baseline
.a
 0.90 (0.72, 1.98) 0.92 (0.65, 1.02) 0.91 (0.75, 1.02) 0.563 
Post-intervention
 a
 1.00 (0.77, 1.22) 0.95 (0.69, 1.01) 0.88 (0.72, 1.01)  
Change from baseline
 a
 0.05 (-0.76, 
0.26)** 
0.03 (-0.10, 
0.24)** 
-0.02 (-0.08, 
0.04) 
<0.0001 
Abbreviations: BPM = Beats per Minute; stepwise synchronisation = music beat (BPM) / median 
cadence; step length and step time variability were expressed by the Coefficient of Mean 
Deviation about the Median (%). 
a
Median (range); significance of group differences analysed with Kruskal Wallis test; if overall p-
value significant, post hoc pairwise comparisons between groups with Dunn´s multiple 
comparisons test: *p<0.05; **p<0.01. 
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Supplementary Figure 1: Effect of intervention on physical, cognitive, psychosocial 
and total fatigue. 
Figure legend: Abbreviations: MVMI: music- and verbally cued MI; MMI: music-cued 
MI; MI: motor imagery; MFIS: Modified Fatigue Impact Scale. (A) Physical, (B) 
cognitive, (C) psychosocial and (D) total fatigue; medians are shown by lines in the 
centre of the box-plots; the 25th-75th percentiles are indicated by the boxes and the 
range by the whiskers. Square brackets on top of the figures show significant within-
group comparisons between baseline and post-intervention; h-beams indicate 
significant group X time interactions. (D) The dashed line indicates the cut-off score 
for fatigue at 38 points on the total MFIS; *p-value <0.05; **p-value <0.01; ***p-value 
<0.001. 
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Supplementary Figure 2: Effect of intervention on physical and psychological quality 
of life. 
Figure legend: Abbreviations: MVMI: music- and verbally cued MI; MMI: music-cued 
MI; MI: motor imagery; MSIS-29: Multiple Sclerosis Impact Scale-29. (A) Physical 
and (B) psychological quality of life; medians are shown by lines in the centre of the 
box-plots; the 25th-75th percentiles are indicated by the boxes and the range by the 
whiskers. Square brackets on top of the figures show significant within-group 
comparisons between baseline and post-intervention; h-beams indicate significant 
group X time interactions; *p-value <0.05; **p-value <0.01; ***p-value <0.001. 
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Figure 3: Effect of intervention on walking speed and walking distance in participants 
with low (EDSS 1.5-3.0) and higher disability levels (EDSS 3.5-4.5). 
Figure legend: Abbreviations: MVMI: music- and verbally cued MI; MMI: music-cued 
MI; MI: motor imagery; T25FW: Timed 25-Foot Walk Test; 6MWT: 6-Minute Walk 
Test. (A) Walking speed and (B) walking distance; small square brackets above the 
figure indicate significant within-group comparisons between baseline and post-
intervention. Between-group comparisons yielded nonsignificant results. Grey and 
black symbols show means and error bars indicate 95% confidence intervals; *p-
value <0.05; **p-value <0.01; ***p-value <0.001. 
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